BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9595961)

  • 1. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Knopman DS
    Neurology; 1998 May; 50(5):1203-5. PubMed ID: 9595961
    [No Abstract]   [Full Text] [Related]  

  • 2. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better?
    Sandson TA
    Neurology; 1999 Feb; 52(3):675-6. PubMed ID: 10025821
    [No Abstract]   [Full Text] [Related]  

  • 3. Metrifonate: update on a new antidementia agent.
    Ringman JM; Cummings JL
    J Clin Psychiatry; 1999 Nov; 60(11):776-82. PubMed ID: 10584768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug treatment for Alzheimer's disease. Treatment with metrifonate warrants multicentre trials.
    Zamar AC; Wise ME; Watson JP
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841012
    [No Abstract]   [Full Text] [Related]  

  • 5. Metrifonate for Alzheimer's disease.
    López-Arrieta JM; Schneider L
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metrifonate for Alzheimer's disease patients.
    Schneider LS
    J Clin Psychiatry; 2000 Mar; 61(3):218-9. PubMed ID: 10817111
    [No Abstract]   [Full Text] [Related]  

  • 7. Metrifonate: overview of safety and efficacy.
    Cummings JL
    Pharmacotherapy; 1998; 18(2 Pt 2):43-6; discussion 79-82. PubMed ID: 9543464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating response to metrifonate.
    Tariot PN
    J Clin Psychiatry; 1998; 59 Suppl 9():33-7. PubMed ID: 9720485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials.
    Farlow MR; Cyrus PA
    Dement Geriatr Cogn Disord; 2000; 11(4):202-11. PubMed ID: 10867446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metrifonate: a new agent for the treatment of Alzheimer's disease.
    Williams BR
    Am J Health Syst Pharm; 1999 Mar; 56(5):427-32. PubMed ID: 10096702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease.
    Schmidt BH; Heinig R
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():15-9. PubMed ID: 9718230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical trial protocol of the Metrifonate in Alzheimer's Trial (MALT).
    McKeith IG
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():2-7. PubMed ID: 9718228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer disease. Irreversible AChE inhibition with metrifonate].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1998 Aug; 21(8):250. PubMed ID: 9758555
    [No Abstract]   [Full Text] [Related]  

  • 14. Metrifonate.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Dec; 11(6):490-6. PubMed ID: 9413706
    [No Abstract]   [Full Text] [Related]  

  • 15. Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.
    Kaufer D
    Dement Geriatr Cogn Disord; 1998; 9 Suppl 2():8-14. PubMed ID: 9718229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metrifonate. A viewpoint.
    Taylor P
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413708
    [No Abstract]   [Full Text] [Related]  

  • 17. Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.
    Morris JC; Cyrus PA; Orazem J; Mas J; Bieber F; Ruzicka BB; Gulanski B
    Neurology; 1998 May; 50(5):1222-30. PubMed ID: 9595967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metrifonate. A viewpoint.
    Giacobini E
    Drugs Aging; 1997 Dec; 11(6):497. PubMed ID: 9413707
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of metrifonate therapy on caregivers of patients with Alzheimer's disease: results from the MALT clinical trial. Metrifonate in Alzheimer's Disease Trial.
    Shikiar R; Shakespeare A; Sagnier PP; Wilkinson D; McKeith I; Dartigues JF; Dubois B
    J Am Geriatr Soc; 2000 Mar; 48(3):268-74. PubMed ID: 10733052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group.
    Cummings JL; Cyrus PA; Bieber F; Mas J; Orazem J; Gulanski B
    Neurology; 1998 May; 50(5):1214-21. PubMed ID: 9595966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.